# WALLET SHARE & COMPETITOR ANALYSIS - EXECUTIVE SUMMARY
**Generated: November 3, 2025**

## ðŸ“Š ANALYSIS OVERVIEW

This analysis provides deep insights into IBSA's wallet share positioning, competitive landscape, and growth opportunities across 221,266 HCP records.

---

## ðŸŽ¯ KEY FINDINGS

### 1. **Current Wallet Share Position**
- **Active IBSA Prescribers**: 30,760 HCPs (13.9% of total)
- **Average IBSA Wallet Share**: 87.4% (among active prescribers)
- **Median IBSA Wallet Share**: 100.0%
- **Insight**: High loyalty among existing prescribers, but significant opportunity in non-prescribers

### 2. **HCP Segmentation by Wallet Share Tier**

| Tier | HCPs | % of Total | TRx Volume | % of Volume | Strategy |
|------|------|------------|------------|-------------|----------|
| **Retention (70-100%)** | 25,895 | 11.7% | 103,253 | 89.0% | Protect & Maintain |
| **Loyalty (50-70%)** | 437 | 0.2% | 3,070 | 2.6% | Expand Share |
| **Expansion (30-50%)** | 865 | 0.4% | 3,304 | 2.8% | Accelerate Growth |
| **Growth (10-30%)** | 2,027 | 0.9% | 4,091 | 3.5% | Competitive Capture |
| **Conversion (0-10%)** | 1,536 | 0.7% | 2,305 | 2.0% | New User Acquisition |
| **Non-Prescriber** | 190,506 | 86.1% | 0 | 0.0% | Market Penetration |

**Key Insight**: 89% of volume comes from high-loyalty prescribers (70-100% share). Significant opportunity exists in converting non-prescribers and growing share in lower tiers.

### 3. **Competitive Landscape**
- **Total Market TRx**: 772,248
- **Current IBSA TRx**: 116,023 (15.0% market share)
- **Addressable Competitor TRx**: 656,225
- **Potential Capture (15% goal)**: 98,434 TRx
- **Revenue Impact**: +85% potential growth from competitive displacement

### 4. **Growth Potential Segmentation**

| Growth Potential | HCPs | % of Total | Strategy |
|------------------|------|------------|----------|
| **High (>10% points)** | 3,681 | 1.7% | Priority targeting, high resource allocation |
| **Medium (5-10% points)** | 191,617 | 86.6% | Systematic cultivation, focused detailing |
| **Low (0-5% points)** | 25,968 | 11.7% | Retention and maintenance |

**Key Insight**: 86.6% of HCPs have medium growth potential (5-10% point increase), representing massive opportunity for systematic share capture programs.

---

## ðŸ“ˆ PRODUCT-SPECIFIC INSIGHTS

### **Tirosint**
- Prescriber Penetration: Strong
- Share Distribution: Concentrated in high-share HCPs
- Opportunity: Expand to mid-share prescribers

### **Flector**
- Prescriber Penetration: Moderate
- Share Distribution: Broader distribution
- Opportunity: New prescriber acquisition in pain management

### **Licart**
- Prescriber Penetration: Lower
- Share Distribution: Niche prescribers
- Opportunity: Education and awareness in cardiology

---

## ðŸ’° ADDRESSABLE MARKET OPPORTUNITY

### **By the Numbers**
```
Current State:
â”œâ”€ Total Market: 772,248 TRx
â”œâ”€ IBSA Current: 116,023 TRx (15.0%)
â””â”€ Competitor:   656,225 TRx (85.0%)

Growth Scenario (15% Capture):
â”œâ”€ Target Capture: 98,434 TRx
â”œâ”€ New IBSA Total: 214,457 TRx
â””â”€ New Market Share: 27.8% (+12.8 points)
```

### **Strategic Segments**
1. **Retention Tier (70-100% share)**: Protect 103K TRx base
2. **Growth Tiers (10-70% share)**: Expand by 10K TRx
3. **Conversion (<10% share)**: Add 15K TRx
4. **Non-Prescribers**: New 70K TRx opportunity

---

## ðŸŽ¯ STRATEGIC RECOMMENDATIONS

### **1. Protect High-Value Base (Priority 1)**
- **Target**: 25,895 HCPs with 70-100% share
- **Current Volume**: 103K TRx (89% of total)
- **Action**: Enhanced loyalty programs, proactive engagement
- **Risk**: High-value targets for competitors

### **2. Systematic Share Capture (Priority 2)**
- **Target**: 191,617 HCPs with 5-10% growth potential
- **Opportunity**: Largest addressable segment
- **Action**: Structured detailing programs, sampling strategies
- **Timeline**: 12-18 month systematic campaign

### **3. Competitive Displacement (Priority 3)**
- **Target**: HCPs with competitor-dominant prescribing
- **Opportunity**: 656K competitor TRx addressable
- **Action**: Comparative messaging, switch programs
- **Focus**: Recent competitor concerns/discontinuations

### **4. Market Penetration (Priority 4)**
- **Target**: 190,506 non-prescribers
- **Opportunity**: Greenfield expansion
- **Action**: Awareness campaigns, sample programs
- **Challenge**: Requires higher investment per HCP

---

## ðŸ“Š CHARTS FOR PRESENTATION DECK

All charts have been generated in high-resolution PNG format, ready for PowerPoint:

### **Chart 1: Wallet Share Distribution**
**File**: `1_wallet_share_distribution.png`
- Pie chart showing HCP distribution by wallet tier
- Bar chart with counts and percentages
- **Use for**: Executive overview of current positioning

### **Chart 2: Competitor Landscape**
**File**: `2_competitor_landscape.png`
- Competitor product distribution
- IBSA vs Competitor market share
- Competitive strength analysis
- Wallet share distribution by tier
- **Use for**: Competitive positioning discussion

### **Chart 3: Growth Potential Analysis**
**File**: `3_growth_potential_analysis.png`
- Growth potential tier distribution
- Scatter plot: growth vs current share
- Average potential by wallet tier
- Current volume by tier
- **Use for**: Opportunity assessment and targeting

### **Chart 4: Product-Specific Wallet Share**
**File**: `4_product_specific_wallet_share.png`
- Prescriber penetration by product (Tirosint, Flector, Licart)
- Share distribution for each product
- **Use for**: Product-level strategy discussions

### **Chart 5: Executive Summary Dashboard**
**File**: `5_executive_summary_dashboard.png`
- KPI cards: Active prescribers, average share, high-potential HCPs
- Wallet tier distribution
- Overall market share
- Growth opportunity by tier
- **Use for**: Opening slide or executive summary

---

## ðŸ“ FILES LOCATION

```
ibsa-poc-eda/outputs/wallet-share-analysis/
â”œâ”€â”€ deck-charts/
â”‚   â”œâ”€â”€ 1_wallet_share_distribution.png (131 KB)
â”‚   â”œâ”€â”€ 2_competitor_landscape.png (123 KB)
â”‚   â”œâ”€â”€ 3_growth_potential_analysis.png (244 KB)
â”‚   â”œâ”€â”€ 4_product_specific_wallet_share.png (103 KB)
â”‚   â””â”€â”€ 5_executive_summary_dashboard.png (214 KB)
â””â”€â”€ wallet_share_analysis_summary.json (detailed metrics)
```

---

## ðŸ’¡ NEXT STEPS

1. **Immediate Actions**
   - Insert charts into presentation deck
   - Review findings with commercial leadership
   - Validate opportunity sizing with finance

2. **Strategic Planning**
   - Develop tiered targeting strategy
   - Allocate resources by growth potential
   - Create competitive displacement programs

3. **Operational Execution**
   - Build HCP segmentation in CRM
   - Deploy field force with prioritized call plans
   - Track share shift metrics monthly

4. **Measurement & Optimization**
   - Monitor wallet share by tier
   - Measure competitive displacement rate
   - Adjust strategies based on performance

---

## ðŸ“ž SUPPORT

For questions or additional analysis:
- **Script**: `phase3_wallet_share_competitor_analysis.py`
- **Data Source**: Phase 7 outputs with competitor breakdown
- **Re-run**: Activate environment and run script for updated charts

---

**Analysis Date**: November 3, 2025
**Data Coverage**: 221,266 HCP records
**Market Coverage**: 772,248 TRx total addressable market
